Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant

被引：6
|
作者：
Brunvand, Mark W. [1 ]
Bitter, Mitchell [2 ]
机构：
[1] Rocky Mt Blood & Marrow Transplant Program, Denver, CO 80218 USA
[2] Unipath, Denver, CO USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 03期
关键词：
SYSTEMIC AL AMYLOIDOSIS; CHEMOTHERAPY; SURVIVAL;
D O I：
10.3324/haematol.2009.013102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：519 / 521
页数：3
相关论文
共 30 条
  • [1] Progressive Renal Light Chain Amyloidosis With the Absence of Detectable Free Monoclonal Light Chains After an Autologous Hematopoietic Stem Cell Transplant for Amyloid Light Chain Amyloidosis
    Roth, Rachel M.
    Benson, Don
    Hebert, Lee A.
    Bissell, Michael G.
    Satoskar, Anjali A.
    Nadasdy, Tibor
    Brodsky, Sergey V.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (09) : 1304 - 1308
  • [2] Serum-free light chain and heavy-light chains normalization as markers for negative measurable residual disease in Multiple Myeloma after autologous stem cell transplant
    Bergantim, Rui
    Lacerda, Luisa
    Trigo, Mariana
    Baptista, Pedro
    Henriques, Marta
    Pardal, Andre
    Cardoso, Maria Joao
    Trigo, Fernanda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S58 - S59
  • [3] The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains
    Pratt, G
    Mead, GP
    Godfrey, KR
    Hu, Y
    Evans, ND
    Chappell, MJ
    Lovell, R
    Bradwell, AR
    LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 21 - 28
  • [4] Prognostic value of serum-free light chain monitoring in patients receiving autologous stem cell transplantation
    Ozkurt, Z. N.
    Haznedar, R.
    Aki, Z.
    Yagci, M.
    Sucak, G. T.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S150 - S151
  • [5] Changes in serum-free light chain concentrations as a marker of disease response in myeloma patients after autologous stem cell transplantation
    Pratt, G
    Mead, G
    Lovell, R
    Bradwell, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 30 - 30
  • [6] Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation
    Emilce Alejandre, Mariel
    Arturo Pavlovsky, Miguel
    Remaggi, Guillermina
    Corrado, Claudia
    Fernandez, Isolda
    Milone, Gustavo
    Pavlovsky, Astrid
    Madalena, Leticia
    Pandolfo, Marcela
    Laura Facio, Maria
    Bresciani, Pablo
    Pavlovsky, Santiago
    Pizzolato, Marco A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (06) : 1093 - 1097
  • [7] Evaluation of serum free light chains and outcome in multiple myeloma patients with an intact monoclonal immunoglobulin treated with autologous stem cell transplantation
    Trieu, Y.
    Xu, W.
    Chen, C. I.
    Kukreti, V.
    Mikhael, J.
    Trudel, S.
    Reece, D. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 206 - 207
  • [8] Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
    Parmar, Harsh
    Al Saleh, Abdullah S.
    Visram, Alissa
    Warsame, Rahma
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Dingli, David
    Muchtar, Eli
    Hayman, Suzanne
    Kapoor, Prashant
    Buadi, Francis
    Dispenzieri, Angela
    Lacy, Martha
    Gertz, Morie
    Kumar, Shaji
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (04): : 309.e1 - 309.e5
  • [9] Evaluation of Serum Free Light Chains and Outcome in Multiple Myeloma Patients with an Intact Monoclonal Immunoglobulin Treated with Autologous Stem Cell Transplantation.
    Trieu, Young
    Xu, Wei
    Anglin, Peter
    Chen, Christine
    Kukreti, Vishal
    Trudel, Suzanne
    Reece, Donna E.
    BLOOD, 2008, 112 (11) : 1142 - 1142
  • [10] Free light chains in serum are a prognostic marker of primary AL amyloidosis after peripheral stem cell autografting
    Leleu, Xavier
    HEMATOLOGIE, 2006, 12 (03): : 158 - 158
123